Scarica l'app Stockscreener
9.28
1.80%
-0.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.45
Aprire:
$9.47
Volume 24 ore:
100.78K
Relative Volume:
0.15
Capitalizzazione di mercato:
$283.08M
Reddito:
$40.61M
Utile/perdita netta:
$-29.07M
Rapporto P/E:
-9.2054
EPS:
-1.0081
Flusso di cassa netto:
$-26.70M
1 W Prestazione:
+0.43%
1M Prestazione:
-33.57%
6M Prestazione:
-13.43%
1 anno Prestazione:
-62.85%
Intervallo 1D:
$9.28
$9.58
Intervallo di 1 settimana:
$8.95
$9.7195
Portata 52W:
$8.27
$28.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
9.28 | 283.08M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
99.05 | 171.40B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.54 | 119.65B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
297.24 | 114.01B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.47 | 64.45B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.09 | 50.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-05-08 | Ripresa | Stifel | Buy |
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc.CLPT - GlobeNewswire Inc.
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates - Zacks Investment Research
ClearPoint Neuro Director R. John Fletcher Receives 993 Shares as Director Compensation - Kalkine Media
319 shares go to director Timothy T. Richards as fee payment from ClearPoint Neuro (CLPT). - Stock Titan
ClearPoint Neuro (NasdaqCM:CLPT) Stock Forecast & Analyst Predictions - simplywall.st
Top Conexeu Sciences (CNXU) Competitors 2026 - marketbeat.com
Conexeu Sciences (CNXU) Short Interest & Short Float | Updated Sep 2026 - marketbeat.com
Hemostemix files for price protection in $1M pr... - Pluang
ClearPoint Neuro stock slips as revenue misses estimates - ad-hoc-news.de
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment - Yahoo Finance
ClearPoint Neuro Company Profile & Introduction - Moomoo
How (CLPT) Movements Inform Risk Allocation Models - Stock Traders Daily
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $25 - Moomoo
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - ACCESS Newswire
ClearPoint Neuro stock holds recent gains as earnings and analyst targets frame the next move - AD HOC NEWS
ClearPoint (CLPT) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Finish 11.80% Up on the DaySubscription Growth Report - vinanet.vn
ClearPoint (CLPT) Results at a Glance: The Bottom-Line Figure Trails Its Comparison in the Current Update; Trading Response: Shares Fall 2.01% at the CloseBuyback Announcement Report - vinanet.vn
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Conway Capital Management Inc. Makes New $1.66 Million Investment in ClearPoint Neuro, Inc. $CLPT - MarketBeat
ClearPoint Neuro (CLPT) Edges Lower as Shares Consolidate Between $14.57 Support and $16.11 ResistanceBullish Sentiment - vinanet.vn
ClearPoint Neuro (CLPT) Edges Lower as Shares Consolidate Between $14.57 Support and $16.11 ResistanceBullish Sentiment - vinanet.vn
(CLPT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ClearPoint Neuro (CLPT): MAK Capital group discloses 7.8% ownership in 13G/A - Stock Titan
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - AOL.com
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - The Globe and Mail
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - The Globe and Mail
ClearPoint Neuro (CLPT) Jumps 6.12% to $14.21: Key Levels to WatchSell Signal Alerts - vinanet.vn
ClearPoint Neuro (NASDAQ:CLPT) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Have Lowered Expectations For ClearPoint Neuro, Inc. (NASDAQ:CLPT) After Its Latest Results - 富途牛牛
Clearpoint Neuro Inc (CLPT) Stock News Today - TradingKey
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
Analysts Have Lowered Expectations For ClearPoint Neuro, Inc. (NASDAQ:CLPT) After Its Latest Results - Moomoo
ClearPoint Neuro, Inc. (CLPT) Options Chain - Yahoo! Finance Canada
CLPT Looks 4.6% Overvalued on GF Value™ Ahead of Tuesday Market Drop - GuruFocus
ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case (CLPT) - Seeking Alpha
ClearPoint Neuro Updates Q2 Results and 2026 Outlook - The Globe and Mail
ClearPoint Neuro (CLPT) investors disclose 7.45% beneficial ownership stake - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Cuts Target Price to $25 - Moomoo
Stifel cuts Clearpoint Neuro stock price target on guidance cut - Investing.com
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com South Africa
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com Nigeria
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com India
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks - Benzinga
CLPT Looks 4.7% Overvalued on GF Value™ - GuruFocus
CLPT Looks 4.7% Overvalued on GF Value™ - GuruFocus
How Does ClearPoint Neuro Inc (CLPT) Perform in Q2? EPS at -$0.3 - GuruFocus
Earnings call transcript: Clearpoint Neuro Q2 2026 misses estimates as shares fall - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clearpoint Neuro Inc Azioni (CLPT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President |
Jun 29 '26 |
Sale |
19.38 |
20,000 |
387,600 |
116,842 |
| BURNETT JOSEPH | CEO and President |
Jun 29 '26 |
Option Exercise |
2.50 |
20,000 |
50,000 |
136,842 |
| JOSEPH BURNETT | Director |
Jun 29 '26 |
Proposed Sale |
18.48 |
20,000 |
369,600 |
0 |
| BURNETT JOSEPH | CEO and President |
Jun 17 '26 |
Option Exercise |
2.50 |
60,000 |
150,000 |
176,842 |
| BURNETT JOSEPH | CEO and President |
Jun 17 '26 |
Sale |
17.79 |
60,000 |
1,067,400 |
116,842 |
| BURNETT JOSEPH | CEO and President |
Jun 17 '26 |
Sale |
17.94 |
1,843 |
33,063 |
191,388 |
| JOSEPH M BURNETT TRUST | Affiliate of Director |
Jun 17 '26 |
Proposed Sale |
13.34 |
1,843 |
24,586 |
0 |
| JOSEPH BURNETT | Director |
Jun 17 '26 |
Proposed Sale |
13.34 |
60,000 |
800,400 |
0 |
| Richards Timothy T. | Director |
Jun 04 '26 |
Option Exercise |
10.00 |
500 |
5,000 |
87,698 |
| Richards Timothy T. | Director |
Jun 01 '26 |
Sale |
12.17 |
5,415 |
65,901 |
87,198 |
1.90%
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):